| RS2147759475 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147759662 |
HADHA
|
Health Risk |
Pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS2147760387 |
ATRX
|
Health Risk |
Likely pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS2147761759 |
ATRX
|
Health Risk |
Likely pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS2147762267 |
HADHA
|
Health Risk |
Pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS2147762308 |
HADHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial trifunctional protein deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS2147762411 |
HADHA
|
Health Risk |
Likely pathogenic |
Mitochondrial trifunctional protein deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS2147762900 |
PLP1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 2, Hereditary spastic paraplegia 2 |
| RS2147764198 |
PLP1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 2, Hereditary spastic paraplegia 2 |
| RS2147764222 |
PLP1
|
Health Risk |
Likely pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS2147764477 |
PLP1
|
Health Risk |
Pathogenic |
— |
| RS2147764567 |
PLP1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 2, Hereditary spastic paraplegia 2 |
| RS2147764593 |
PLP1;RAB9B
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 2, Hereditary spastic paraplegia 2 |
| RS2147764596 |
PLP1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 2, Hereditary spastic paraplegia 2 |
| RS2147764616 |
PLP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Pelizaeus-Merzbacher disease |
| RS2147764634 |
PLP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia, Pelizaeus-Merzbacher disease |
| RS2147765101 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147765197 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147765873 |
PLP1
|
Health Risk |
Pathogenic |
— |
| RS2147765890 |
PLP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 2, Hereditary spastic paraplegia 2 |
| RS2147766068 |
PLP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 2, See cases |
| RS2147766482 |
PHKA1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXd, Glycogen storage disease IXd |
| RS2147766716 |
HADHA
|
Health Risk |
Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS2147766937 |
PLP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 2, Pelizaeus-Merzbacher disease |
| RS2147766958 |
PLP1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 2, Pelizaeus-Merzbacher disease |
| RS2147766999 |
PLP1
|
Health Risk |
Pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS2147767061 |
PLP1
|
Health Risk |
Pathogenic |
— |
| RS2147768028 |
PLP1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 2, Pelizaeus-Merzbacher disease |
| RS2147768516 |
HADHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial trifunctional protein deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS2147769502 |
HADHA
|
Health Risk |
Pathogenic |
— |
| RS2147769775 |
MED12
|
Health Risk |
Likely pathogenic |
FG syndrome, FG syndrome |
| RS2147769993 |
HADHA
|
Health Risk |
Pathogenic |
Mitochondrial trifunctional protein deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS2147770199 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147770243 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2147770394 |
DLG3
|
Health Risk |
Likely pathogenic |
— |
| RS2147770608 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147770618 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147771579 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS2147771642 |
DLG3
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 90 |
| RS2147773762 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2147774632 |
MED12
|
Health Risk |
Pathogenic |
FG syndrome 1, MED12-related intellectual disability syndrome |
| RS2147776049 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147776168 |
TFE3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, X-linked |
| RS2147776175 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, COL4A5-related disorder |
| RS2147776373 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2147776381 |
TFE3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, X-linked |
| RS2147776445 |
TFE3
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, X-linked |
| RS2147776463 |
TFE3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, X-linked |
| RS2147776527 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147776565 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147776596 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147776797 |
COL4A5
|
Health Risk |
Pathogenic |
Hepatocellular carcinoma, Hepatocellular carcinoma |
| RS2147777343 |
TFE3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, X-linked |
| RS2147777346 |
TFE3
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Intellectual developmental disorder |
| RS2147777425 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147777495 |
COL4A5
|
Health Risk |
Pathogenic |
Alport syndrome, Alport syndrome |
| RS2147777529 |
KDM6A
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Familial cancer of breast |
| RS2147779510 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
FG syndrome 1, Cholestasis-pigmentary retinopathy-cleft palate syndrome |
| RS2147779873 |
PHKA1
|
Health Risk |
Pathogenic |
Glycogen storage disease IXd, Glycogen storage disease IXd |
| RS2147780368 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, FG syndrome |
| RS2147781020 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147781182 |
HADHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS2147781328 |
PHKA1
|
Health Risk |
Pathogenic |
Glycogen storage disease IXd, Glycogen storage disease IXd |
| RS2147782173 |
MED12
|
Health Risk |
Likely pathogenic |
Blepharophimosis - intellectual disability syndrome, MKB type |
| RS2147782314 |
SDCCAG8
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Senior-Loken syndrome 7 |
| RS2147783150 |
MED12
|
Health Risk |
Likely pathogenic |
— |
| RS2147783158 |
MED12
|
Health Risk |
Pathogenic |
FG syndrome 1, FG syndrome 1 |
| RS2147783395 |
UPF3B
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability 14, Syndromic X-linked intellectual disability 14 |
| RS2147783712 |
MED12
|
Health Risk |
Likely pathogenic |
— |
| RS2147784234 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147784271 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147784383 |
HADHA
|
Health Risk |
Pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS2147785143 |
MED12
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2147787275 |
UPF3B
|
Health Risk |
Pathogenic |
— |
| RS2147787295 |
UPF3B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Syndromic X-linked intellectual disability 14 |
| RS2147787331 |
UPF3B
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability 14, Syndromic X-linked intellectual disability 14 |
| RS2147787964 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147787972 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147788213 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147788229 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147788399 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147789622 |
MED12
|
Health Risk |
Likely pathogenic |
— |
| RS2147791162 |
CHM
|
Health Risk |
Likely pathogenic |
Choroideremia, Choroideremia |
| RS2147791994 |
MED12
|
Health Risk |
Pathogenic |
Cholestasis-pigmentary retinopathy-cleft palate syndrome, Cholestasis-pigmentary retinopathy-cleft palate syndrome |
| RS2147796647 |
MED12
|
Health Risk |
Likely pathogenic |
FG syndrome 1, Blepharophimosis - intellectual disability syndrome |
| RS2147796671 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147797124 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147797143 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147797210 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147797835 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
FG syndrome 1, FG syndrome 1 |
| RS2147798001 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147798012 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147798059 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147798143 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147798207 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147798228 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147799052 |
PHKA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2147802765 |
UPF3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2147805055 |
DOCK6
|
Health Risk |
Likely pathogenic |
— |
| RS2147805923 |
MED12
|
Health Risk |
Pathogenic/Likely pathogenic |
FG syndrome 1, Blepharophimosis - intellectual disability syndrome |